Literature DB >> 2439530

Immunogenicity of human immunodeficiency virus (HIV) reverse transcriptase: detection of high levels of antibodies to HIV reverse transcriptase in sera of homosexual men.

R Chatterjee, C R Rinaldo, P Gupta.   

Abstract

Immunoglobulin isolated from sera of homosexual men infected with human immunodeficiency virus (HIV) inhibited the reverse transcriptase (RT) activity of HIV. The inhibitory activity was specifically directed against HIV RT, and not against other mammalian retrovirus RT, including human T-lymphotropic virus type I. The relative titer of anti-RT antibody was significantly higher in asymptomatic men than in patients with lymphadenopathy or acquired immune deficiency syndrome (AIDS)-related complex. There was no correlation between the relative titer of anti-RT antibody and the relative titers of antibodies to major virion structural protein as determined by the enzyme-linked immunosorbent assay (ELISA) technique. These data suggest that antibodies to HIV RT may be related to the clinical status and possibly to the different degree of HIV replication in HIV-infected homosexual men.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439530     DOI: 10.1007/bf00915727

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  19 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Antibody response in cats to feline leukemia virus reverse transcriptase under natural conditions of exposure to the virus.

Authors:  P C Jacquemin; C Saxinger; R C Gallo; W D Hardy; M Essex
Journal:  Virology       Date:  1978-12       Impact factor: 3.616

3.  Inhibition of the reverse transcriptase of bovine leukemia virus by antibody in sera from leukemic cattle and immunological characterization of the enzyme.

Authors:  K D Wuu; D C Graves; J F Ferrer
Journal:  Cancer Res       Date:  1977-05       Impact factor: 12.701

4.  Inhibition of reverse transcriptases of primate type C viruses by 7S immunoglobulin from patients with leukaemia.

Authors:  E V Prochownik; W H Kirsten
Journal:  Nature       Date:  1976-03-04       Impact factor: 49.962

5.  Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients.

Authors:  W G Robey; B Safai; S Oroszlan; L O Arthur; M A Gonda; R C Gallo; P J Fischinger
Journal:  Science       Date:  1985-05-03       Impact factor: 47.728

6.  Identification of HTLV-III/LAV sor gene product and detection of antibodies in human sera.

Authors:  N C Kan; G Franchini; F Wong-Staal; G C DuBois; W G Robey; J A Lautenberger; T S Papas
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

7.  Methods in laboratory investigation. Application of the indirect enzyme-linked immunosorbent assay microtest to the detection and surveillance of human t cell leukemia-lymphoma virus.

Authors:  C Saxinger; R C Gallo
Journal:  Lab Invest       Date:  1983-09       Impact factor: 5.662

Review 8.  Antigens of human T-lymphotropic virus type III/lymphadenopathy-associated virus.

Authors:  M Essex; J Allan; P Kanki; M F McLane; G Malone; L Kitchen; T H Lee
Journal:  Ann Intern Med       Date:  1985-11       Impact factor: 25.391

9.  Lymphadenopathy-associated virus: from molecular biology to pathogenicity.

Authors:  L Montagnier
Journal:  Ann Intern Med       Date:  1985-11       Impact factor: 25.391

10.  Transformation of different phenotypic types of human bone marrow T-lymphocytes by HTLV-1.

Authors:  P D Markham; S Z Salahuddin; B Macchi; M Robert-Guroff; R C Gallo
Journal:  Int J Cancer       Date:  1984-01-15       Impact factor: 7.396

View more
  5 in total

1.  Characterization of human immunodeficiency virus type 1 reverse transcriptase by using monoclonal antibodies: role of the C terminus in antibody reactivity and enzyme function.

Authors:  M Tisdale; P Ertl; B A Larder; D J Purifoy; G Darby; K L Powell
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

2.  Use of cryopreserved normal peripheral blood lymphocytes for isolation of human immunodeficiency virus from seropositive men.

Authors:  R Balachandran; P Thampatty; C Rinaldo; P Gupta
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

3.  Cross-sectional study of reverse transcriptase-inhibiting antibody as a marker of acquired immune deficiency syndrome.

Authors:  M Advani; D T Imagawa; M H Lee; K Sano; F Morales; R T Mitsuyasu; R Detels
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

4.  Measurement of levels of human immunodeficiency virus type 1 reverse transcriptase (RT) and RT activity-blocking antibody in human serum by a new standardized colorimetric assay.

Authors:  R J Awad; G E Corrigan; D H Ekstrand; R Thorstensson; C F Källander; J S Gronowitz
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

5.  Prognostic value of serum immunoglobulin A antibodies to pol gene products during HIV-1 infection.

Authors:  A Quesnel; B Pozzetto; P Moja; F Grattard; F R Lucht; J L Touraine; O G Gaudin; C Genin
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.